This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Symyx's Net Loss Narrows In 1Q

Once these most recent quarterly results are finalized, they will be run through Ratings' model and our ratings will be adjusted accordingly. To keep up to date on all of our ratings, visit Ratings Screener.

On April 29, 2009, Symyx Technologies (SMMX) reported that its net loss during Q1 FY09 narrowed, benefitting from lower operating expenses as a result of restructuring actions undertaken in Q4 FY08. Net loss for the latest first quarter declined to $3.11 million or $0.09 per share from $6.79 million or $0.20 per share in Q1 FY08. The most recent consensus estimate was a loss of $0.12 per share.

Revenue during Q1 FY09 revenue decreased 9.5% to $33.39 million from $36.91 million a year ago. Service revenue dropped 9.8% to $16.70 million, and product revenue slipped 40.5% to $2.72 million. However, revenue from the license fees, content and royalties inched up 1.1% to $13.98 million from $13.82 million in Q1 FY08. Segment-wise, revenue from the Symyx Software rose 8.6% to $21.75 million from $20.02 million. On the flipside, revenue from the Symyx High Productivity Research (HPR) was $11.64 million, down 31.0% from $16.88 million due to reduced research service revenue from the ExxonMobil and lower tools sales.

Symyx signed a partnership with Thermo Fisher Scientific to provide experiment documentation, decision support, and laboratory information management system (LIMS) needs of scientists. The company also announced the release of the DiscoveryGate Web Service. Recently, SMMX announced launch of the Symyx Contract Development and Manufacturing Organization (CDMO), which helps biopharmaceutical companies to move drug candidates to clinical trials faster and more reliably with integrated formulation development.

Looking ahead to Q2 FY08, Symyx expects its non-GAAP net loss to be in the range of $0.07 per share to $0.03 per share, on revenue between $32.00 million and $36.00 million. For FY09, revenue is anticipated to be in the range of $145.00 million to $155.00 million and non-GAAP diluted earnings per share from breakeven to $0.10.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AAPL $123.25 -0.80%
FB $83.30 0.35%
GOOG $548.13 -1.30%
TSLA $185.15 -2.80%
YHOO $45.10 1.42%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs